Company overview
Tend is a dental service organization providing innovative, patient-centered dental care through modern studios offering personalized treatment plans, online booking, and advanced technologies like low-noise drills and quick x-rays. Services include general dentistry, invisible braces, emergency care, oral surgery, and pediatric dentistry. With over 25 studios and 100,000 members nationwide, Tend focuses on hospitality, technology integration, and revenue cycle management to enhance the patient experience.
Tend Dental is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include tend dental, dental service organization, patient-centered dentistry, dental technology, modern dental care.
Structured facts
- Website
- https://www.hellotend.com
- Markets served
- United States & Americas
- Keywords
- tend dental, dental service organization, patient-centered dentistry, dental technology, modern dental care
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
Frequently asked questions
- What dental services does Tend offer?
- Tend provides comprehensive dental services including general care, invisible Breezy Braces, emergency care, oral surgery, and pediatric dentistry, delivered through personalized treatment plans.
- What technologies does Tend use to improve patient experience?
- Tend utilizes online booking, in-studio treatment screens, patient portals, low-noise drills, 20-second x-rays, and HIPAA-compliant apps for seamless access.
- Where are Tend's dental studios located?
- Tend operates over 25 studios nationwide, initially launched in New York City with expansions to Boston, Washington D.C., and other areas.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
